163 related articles for article (PubMed ID: 24604338)
1. Combination of intravitreal bevacizumab and systemic therapy for choroidal metastases from lung cancer: report of two cases and a systematic review of literature.
Maturu VN; Singh N; Bansal P; Rai Mittal B; Gupta N; Behera D; Gupta A
Med Oncol; 2014 Apr; 31(4):901. PubMed ID: 24604338
[TBL] [Abstract][Full Text] [Related]
2. Choroidal metastasis as a presenting manifestation of lung cancer: a report of 3 cases and systematic review of the literature.
Singh N; Kulkarni P; Aggarwal AN; Mittal BR; Gupta N; Behera D; Gupta A
Medicine (Baltimore); 2012 Jul; 91(4):179-194. PubMed ID: 22732948
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal bevacizumab in the successful management of choroidal metastases secondary to lung and breast cancer unresponsive to systemic therapy: a case series.
Fenicia V; Abdolrahimzadeh S; Mannino G; Verrilli S; Balestrieri M; Recupero SM
Eye (Lond); 2014 Jul; 28(7):888-91. PubMed ID: 24763241
[TBL] [Abstract][Full Text] [Related]
4. Effective Treatment with Intravitreal Injection of Bevacizumab for Exudative Retinal Detachment Secondary to Choroidal Metastasis of Non-Small Cell Lung Carcinoma.
Yasui H; Sato K; Takeyama Y; Nishihara H; Maeda M; Gonda H; Suzuki R
Am J Case Rep; 2015 Oct; 16():728-32. PubMed ID: 26460101
[TBL] [Abstract][Full Text] [Related]
5. Complete regression of a non-small cell lung cancer choroidal metastasis with intravitreal bevacizumab.
D'Antonio C; Viterbo A; Romiti A; Enrici MM; Lauro S; Marchetti P
J Thorac Oncol; 2012 Feb; 7(2):468-9. PubMed ID: 22252564
[No Abstract] [Full Text] [Related]
6. Efficacy of bevacizumab (Bev) plus chemotherapy (CT) compared to CT alone in previously untreated locally advanced or metastatic non-small cell lung cancer (NSCLC): systematic review and meta-analysis.
Botrel TE; Clark O; Clark L; Paladini L; Faleiros E; Pegoretti B
Lung Cancer; 2011 Oct; 74(1):89-97. PubMed ID: 21377753
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal administration of bevacizumab in the treatment of choroidal metastasis in a patient with erlotinib-failed pulmonary adenocarcinoma.
Lai CL; Fan KS; Lee YH; Chen HC; Fan WH
Lung Cancer; 2012 Jun; 76(3):496-8. PubMed ID: 22483721
[TBL] [Abstract][Full Text] [Related]
8. The efficacy and safety of pemetrexed plus bevacizumab in previously treated patients with advanced non-squamous non-small cell lung cancer (ns-NSCLC).
Ding L; Liu K; Jiang Z; Chen Q; Zhou N; Liang Y; Gao H; Hong X; Wu H
Tumour Biol; 2015 Apr; 36(4):2491-9. PubMed ID: 25417899
[TBL] [Abstract][Full Text] [Related]
9. Complete regression of choroidal metastasis secondary to non-small-cell lung cancer with intravitreal bevacizumab and oral erlotinib combination therapy.
Kim SW; Kim MJ; Huh K; Oh J
Ophthalmologica; 2009; 223(6):411-3. PubMed ID: 19628953
[TBL] [Abstract][Full Text] [Related]
10. Complete and durable response of choroid metastasis from non-small cell lung cancer with systemic bevacizumab and chemotherapy.
George B; Wirostko WJ; Connor TB; Choong NW
J Thorac Oncol; 2009 May; 4(5):661-2. PubMed ID: 19395911
[TBL] [Abstract][Full Text] [Related]
11. Phase2 study of bevacizumab with carboplatin-paclitaxel for non-small cell lung cancer with malignant pleural effusion.
Tamiya M; Tamiya A; Yamadori T; Nakao K; Asami K; Yasue T; Otsuka T; Shiroyama T; Morishita N; Suzuki H; Okamoto N; Okishio K; Kawaguchi T; Atagi S; Kawase I; Hirashima T
Med Oncol; 2013; 30(3):676. PubMed ID: 23925664
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of bevacizumab on chemotherapy-related acute exacerbation of interstitial lung disease in patients with advanced non-squamous non-small cell lung cancer.
Hamada S; Ichiyasu H; Ikeda T; Inaba M; Kashiwabara K; Sadamatsu T; Sato N; Akaike K; Okabayashi H; Saruwatari K; Tomita Y; Saeki S; Hirata N; Yoshinaga T; Fujii K
BMC Pulm Med; 2019 Apr; 19(1):72. PubMed ID: 30940113
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of bevacizumab-containing chemotherapy for non-squamous non-small cell lung cancer with bone metastases.
Tokito T; Shukuya T; Akamatsu H; Taira T; Ono A; Kenmotsu H; Naito T; Murakami H; Takahashi T; Endo M; Yamamoto N
Cancer Chemother Pharmacol; 2013 Jun; 71(6):1493-8. PubMed ID: 23532208
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy of chemotherapy with carboplatin-paclitaxel plus bevacizumab for previously treated patients with advanced non-small cell carcinoma].
Maki S; Igawa S; Otani S; Nagashima Y; Kimura M; Hiyoshi Y; Ishihara M; Kasajima M; Katono K; Takakura A; Kubota M; Masuda N
Gan To Kagaku Ryoho; 2012 Dec; 39(13):2509-12. PubMed ID: 23235169
[TBL] [Abstract][Full Text] [Related]
15. PRONOUNCE: randomized, open-label, phase III study of first-line pemetrexed + carboplatin followed by maintenance pemetrexed versus paclitaxel + carboplatin + bevacizumab followed by maintenance bevacizumab in patients ith advanced nonsquamous non-small-cell lung cancer.
Zinner RG; Obasaju CK; Spigel DR; Weaver RW; Beck JT; Waterhouse DM; Modiano MR; Hrinczenko B; Nikolinakos PG; Liu J; Koustenis AG; Winfree KB; Melemed SA; Guba SC; Ortuzar WI; Desaiah D; Treat JA; Govindan R; Ross HJ
J Thorac Oncol; 2015 Jan; 10(1):134-42. PubMed ID: 25371077
[TBL] [Abstract][Full Text] [Related]
16. Treatment of ocular metastasis with anti-VEGF: a literature review and case report.
Augustine H; Munro M; Adatia F; Webster M; Fielden M
Can J Ophthalmol; 2014 Oct; 49(5):458-63. PubMed ID: 25284103
[TBL] [Abstract][Full Text] [Related]
17. Successful management of choroidal metastasis with intravitreal ranibizumab injections.
Detorakis ET; Agorogiannis G; Drakonaki EE; Tsilimbaris MK; Pallikaris IG
Ophthalmic Surg Lasers Imaging; 2012 May; 43 Online():e47-51. PubMed ID: 22624796
[TBL] [Abstract][Full Text] [Related]
18. Randomized phase II-III study of bevacizumab in combination with chemotherapy in previously untreated extensive small-cell lung cancer: results from the IFCT-0802 trial†.
Pujol JL; Lavole A; Quoix E; Molinier O; Souquet PJ; Barlesi F; Le Caer H; Moro-Sibilot D; Fournel P; Oster JP; Chatellain P; Barre P; Jeannin G; Mourlanette P; Derollez M; Herman D; Renault A; Dayen C; Lamy PJ; Langlais A; Morin F; Zalcman G;
Ann Oncol; 2015 May; 26(5):908-914. PubMed ID: 25688059
[TBL] [Abstract][Full Text] [Related]
19. A multicenter phase II study of docetaxel, oxaliplatin, and bevacizumab in first-line therapy for unresectable locally advanced or metastatic non-squamous cell histology non-small-cell lung cancer (NSCLC).
Raez LE; Santos ES; Webb RT; Wade J; Brito RA; Karr M; Kennah A; Childs BH
Cancer Chemother Pharmacol; 2013 Nov; 72(5):1103-10. PubMed ID: 24057043
[TBL] [Abstract][Full Text] [Related]
20. Failure of intravitreal bevacizumab in the treatment of choroidal metastasis.
Maudgil A; Sears KS; Rundle PA; Rennie IG; Salvi SM
Eye (Lond); 2015 May; 29(5):707-11. PubMed ID: 25771814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
